tDCS-sham
tDCS-sham is a medical device with 5 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms
RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms
Transcranial Direct Current Stimulation (tDCS) and Virtual Reality Task in Parkinson Disease
Virtual Reality Therapy and Transcranial Direct Current Stimulation in Cerebral Palsy.
Effects of Combined Treatment With tDCS and Cognitive Training in Patients With Fibromyalgia
Clinical Trials (5)
RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms
RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms
Transcranial Direct Current Stimulation (tDCS) and Virtual Reality Task in Parkinson Disease
Virtual Reality Therapy and Transcranial Direct Current Stimulation in Cerebral Palsy.
Effects of Combined Treatment With tDCS and Cognitive Training in Patients With Fibromyalgia
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5